Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Kevin Deane

Concepts (469)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Arthritis, Rheumatoid
123
2026
1176
18.750
 Why?
Autoantibodies
68
2026
1470
8.000
 Why?
Anti-Citrullinated Protein Antibodies
29
2026
116
6.250
 Why?
Rheumatoid Factor
41
2026
175
5.600
 Why?
Peptides, Cyclic
30
2025
266
3.390
 Why?
Autoimmunity
23
2025
908
3.190
 Why?
Antirheumatic Agents
12
2025
298
2.550
 Why?
Malaria
3
2025
66
1.820
 Why?
Rheumatic Diseases
4
2022
92
1.680
 Why?
Sputum
5
2025
309
1.660
 Why?
Methotrexate
5
2025
255
1.520
 Why?
Lung Diseases, Interstitial
11
2025
655
1.360
 Why?
Humans
161
2026
141187
1.220
 Why?
Biomarkers
32
2026
4174
1.210
 Why?
Immunoglobulin A
11
2023
214
1.130
 Why?
HIV Infections
5
2023
3017
1.080
 Why?
Autoimmune Diseases
5
2024
464
1.080
 Why?
Disease Progression
19
2026
2793
1.010
 Why?
Autoantigens
8
2023
422
0.980
 Why?
Arthralgia
3
2025
55
0.920
 Why?
Social Determinants of Health
2
2025
269
0.900
 Why?
Bronchial Diseases
3
2013
37
0.860
 Why?
Early Medical Intervention
2
2014
60
0.850
 Why?
Female
98
2025
75515
0.840
 Why?
Male
85
2025
69783
0.830
 Why?
Extracellular Traps
3
2021
53
0.820
 Why?
Middle Aged
74
2025
34434
0.820
 Why?
Genetic Predisposition to Disease
16
2023
2363
0.820
 Why?
Risk Factors
34
2026
10438
0.800
 Why?
Inflammation
10
2024
2890
0.790
 Why?
Mucous Membrane
2
2024
125
0.750
 Why?
Rheumatology
6
2021
110
0.750
 Why?
Lung Diseases
4
2022
794
0.740
 Why?
Early Diagnosis
8
2022
244
0.740
 Why?
Mosquito Vectors
1
2022
26
0.730
 Why?
Lupus Erythematosus, Systemic
4
2022
234
0.730
 Why?
Insecticides
1
2022
42
0.720
 Why?
Acquired Immunodeficiency Syndrome
1
2023
235
0.710
 Why?
Case-Control Studies
19
2025
3588
0.700
 Why?
Joints
4
2015
106
0.700
 Why?
Precision Medicine
3
2020
434
0.690
 Why?
Prodromal Symptoms
1
2020
19
0.670
 Why?
Adult
59
2025
39177
0.670
 Why?
Epitopes
8
2023
477
0.660
 Why?
Qualitative Research
6
2025
1516
0.620
 Why?
Citrullination
2
2020
13
0.610
 Why?
Histones
4
2023
639
0.600
 Why?
Sexual and Gender Minorities
1
2023
234
0.600
 Why?
Enzyme-Linked Immunosorbent Assay
6
2023
855
0.590
 Why?
Lung
7
2020
4134
0.590
 Why?
Aged
43
2025
24574
0.580
 Why?
Pre-Exposure Prophylaxis
1
2020
239
0.540
 Why?
Asymptomatic Diseases
2
2021
92
0.540
 Why?
Immunoglobulin G
11
2023
900
0.530
 Why?
Transgender Persons
1
2020
198
0.520
 Why?
Pedigree
2
2020
511
0.520
 Why?
Synovitis
2
2023
29
0.510
 Why?
Citrulline
2
2016
45
0.510
 Why?
Focus Groups
4
2025
565
0.510
 Why?
Antibodies, Anti-Idiotypic
2
2015
50
0.500
 Why?
Human Migration
1
2016
24
0.490
 Why?
Transients and Migrants
1
2016
25
0.490
 Why?
Rituximab
3
2025
204
0.480
 Why?
Synovial Membrane
4
2025
121
0.480
 Why?
Arthritis
2
2016
104
0.480
 Why?
Prospective Studies
22
2025
7739
0.470
 Why?
Immunoglobulin M
7
2023
287
0.460
 Why?
Th17 Cells
3
2025
107
0.440
 Why?
Abatacept
2
2025
56
0.440
 Why?
Cytokines
10
2023
2098
0.430
 Why?
Sexual Behavior
2
2016
497
0.430
 Why?
Family
7
2021
680
0.420
 Why?
Pneumonia
1
2020
656
0.420
 Why?
Antipsychotic Agents
1
2016
212
0.410
 Why?
Psychotic Disorders
1
2016
178
0.410
 Why?
Patient Acceptance of Health Care
1
2020
878
0.410
 Why?
Risk-Taking
1
2016
345
0.400
 Why?
Chemokines
2
2012
228
0.400
 Why?
Endothelium, Vascular
4
2013
951
0.400
 Why?
HSP90 Heat-Shock Proteins
1
2013
47
0.390
 Why?
Hydroxychloroquine
2
2025
57
0.380
 Why?
Tanzania
3
2021
59
0.380
 Why?
Risk Reduction Behavior
1
2014
227
0.380
 Why?
Hazardous Substances
1
2012
17
0.380
 Why?
Observational Studies as Topic
2
2024
123
0.370
 Why?
Mass Screening
4
2025
1310
0.360
 Why?
Risk Assessment
8
2025
3490
0.360
 Why?
Susac Syndrome
1
2011
3
0.350
 Why?
Fatty Acids, Omega-3
3
2017
142
0.340
 Why?
Gene-Environment Interaction
1
2012
187
0.330
 Why?
Smoking
9
2024
1601
0.330
 Why?
B-Lymphocytes
3
2025
858
0.330
 Why?
Pregnancy Complications, Cardiovascular
1
2011
83
0.330
 Why?
Protein Processing, Post-Translational
1
2013
464
0.330
 Why?
Mucin-5B
3
2025
222
0.330
 Why?
Malondialdehyde
2
2020
29
0.320
 Why?
Acetaldehyde
2
2020
17
0.320
 Why?
Social Stigma
2
2023
145
0.320
 Why?
Emigration and Immigration
1
2010
56
0.320
 Why?
Health Fairs
1
2009
10
0.320
 Why?
Antibodies, Antinuclear
5
2023
66
0.320
 Why?
Postmenopause
7
2023
371
0.320
 Why?
Incidence
10
2026
2794
0.320
 Why?
Research Design
3
2024
1143
0.310
 Why?
Glucocorticoids
3
2021
533
0.300
 Why?
Uganda
2
2025
87
0.290
 Why?
Antibodies, Bacterial
3
2023
146
0.290
 Why?
Tumor Necrosis Factor-alpha
4
2025
1250
0.290
 Why?
Clinical Trials as Topic
2
2025
1052
0.280
 Why?
Interviews as Topic
3
2025
844
0.270
 Why?
Cross-Sectional Studies
10
2025
5636
0.270
 Why?
B-Cell Activating Factor
2
2024
21
0.260
 Why?
Health Behavior
3
2018
790
0.260
 Why?
Animals
12
2025
37657
0.260
 Why?
Chlamydia trachomatis
2
2025
50
0.250
 Why?
Antibody Formation
4
2023
298
0.250
 Why?
Immunophenotyping
2
2025
329
0.240
 Why?
Antibodies, Antiphospholipid
1
2005
21
0.240
 Why?
Chlamydia Infections
2
2025
80
0.230
 Why?
Qa-SNARE Proteins
1
2025
20
0.230
 Why?
Developing Countries
2
2025
317
0.230
 Why?
Vasculitis
1
2005
68
0.230
 Why?
HLA-B27 Antigen
1
2024
17
0.230
 Why?
Arthritis, Psoriatic
1
2024
21
0.220
 Why?
Complement Factor H
1
2025
79
0.220
 Why?
Longitudinal Studies
5
2025
2902
0.220
 Why?
Complement Activation
2
2025
415
0.210
 Why?
Spondylarthritis
1
2024
50
0.210
 Why?
Prevalence
5
2025
2772
0.210
 Why?
Likelihood Functions
1
2024
147
0.210
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2024
76
0.210
 Why?
Polysaccharides
2
2017
87
0.210
 Why?
Risk
3
2016
904
0.210
 Why?
Clinical Decision-Making
2
2024
339
0.200
 Why?
T-Lymphocytes, Helper-Inducer
1
2024
136
0.200
 Why?
Estrogens
3
2017
367
0.200
 Why?
Africa South of the Sahara
1
2023
46
0.200
 Why?
London
1
2023
47
0.200
 Why?
HLA-DR Antigens
1
2024
228
0.200
 Why?
Protein-Arginine Deiminases
3
2021
16
0.190
 Why?
Down-Regulation
1
2025
641
0.190
 Why?
Time Factors
6
2019
6956
0.190
 Why?
Autophagy
1
2025
287
0.190
 Why?
Periodontal Diseases
1
2023
60
0.190
 Why?
Mouth Mucosa
3
2023
90
0.190
 Why?
Young Adult
10
2025
13673
0.190
 Why?
Immunoglobulin Isotypes
1
2022
36
0.190
 Why?
Trichloroethylene
1
2022
8
0.190
 Why?
Patient Education as Topic
3
2018
778
0.190
 Why?
Transforming Growth Factor beta
1
2025
497
0.190
 Why?
Insecticide-Treated Bednets
1
2022
6
0.190
 Why?
Gender Identity
1
2023
127
0.190
 Why?
Biological Products
2
2022
237
0.180
 Why?
Policy
1
2023
149
0.180
 Why?
Women's Health
5
2017
311
0.180
 Why?
Homosexuality, Male
1
2023
209
0.180
 Why?
Leukocytes, Mononuclear
3
2024
573
0.180
 Why?
Blood Platelets
1
2025
437
0.180
 Why?
CD8-Positive T-Lymphocytes
2
2025
918
0.180
 Why?
Pulmonary Fibrosis
1
2025
400
0.170
 Why?
Sex Factors
5
2020
2058
0.170
 Why?
Organ Specificity
2
2019
312
0.170
 Why?
Lymphocyte Activation
1
2025
1150
0.170
 Why?
Housing
1
2022
145
0.170
 Why?
Neutrophil Activation
1
2021
87
0.170
 Why?
Fatty Acids, Unsaturated
1
2021
98
0.170
 Why?
Hemorrhage
1
2005
760
0.170
 Why?
Epstein-Barr Virus Infections
1
2022
98
0.170
 Why?
Sarcoidosis
1
2022
161
0.160
 Why?
Tumor Necrosis Factor Ligand Superfamily Member 15
1
2020
9
0.160
 Why?
Chemokine CXCL16
1
2020
4
0.160
 Why?
Cytomegalovirus Infections
1
2022
197
0.160
 Why?
Museums
1
2000
12
0.160
 Why?
Intestines
2
2021
357
0.160
 Why?
Severity of Illness Index
8
2022
2892
0.160
 Why?
Sjogren's Syndrome
1
2020
53
0.160
 Why?
Muramidase
1
2020
79
0.160
 Why?
Complement System Proteins
2
2022
333
0.160
 Why?
Public-Private Sector Partnerships
1
2020
45
0.160
 Why?
Toll-Like Receptors
1
2020
189
0.160
 Why?
Pandemics
2
2025
1653
0.160
 Why?
Art Therapy
1
2000
20
0.160
 Why?
Lipopolysaccharide Receptors
1
2020
91
0.150
 Why?
United Kingdom
1
2020
322
0.150
 Why?
Bacteriophages
1
2021
107
0.150
 Why?
C-Reactive Protein
6
2025
418
0.150
 Why?
Attitude
1
2021
261
0.150
 Why?
Retrospective Studies
5
2024
16273
0.150
 Why?
Nuclear Family
1
2019
57
0.150
 Why?
Age Factors
7
2020
3292
0.150
 Why?
Inflammation Mediators
2
2020
519
0.150
 Why?
Gain of Function Mutation
1
2018
34
0.150
 Why?
Gene Expression
2
2022
1491
0.150
 Why?
CD4-Positive T-Lymphocytes
1
2025
1110
0.140
 Why?
Protein Tyrosine Phosphatase, Non-Receptor Type 22
2
2016
50
0.140
 Why?
Mitochondria
2
2025
967
0.140
 Why?
Arthritis, Experimental
1
2020
141
0.140
 Why?
Dexamethasone
1
2020
380
0.140
 Why?
Proteomics
1
2025
1134
0.140
 Why?
Multiple Sclerosis
1
2024
468
0.140
 Why?
Socioeconomic Factors
4
2025
1306
0.140
 Why?
Occupational Exposure
1
2022
348
0.140
 Why?
United States
9
2025
15220
0.140
 Why?
Vascular Stiffness
2
2013
449
0.140
 Why?
HLA-DR4 Antigen
3
2007
77
0.140
 Why?
Monocytes
1
2020
579
0.140
 Why?
Health Services Accessibility
1
2025
1016
0.140
 Why?
Cohort Studies
10
2022
5799
0.130
 Why?
Remission Induction
2
2021
309
0.130
 Why?
Metabolome
1
2020
366
0.130
 Why?
Galactose
1
2017
35
0.130
 Why?
Cellular Senescence
1
2019
205
0.130
 Why?
Military Personnel
2
2021
613
0.130
 Why?
Global Health
1
2020
386
0.130
 Why?
Coronary Disease
2
2017
371
0.130
 Why?
Glycosylation
1
2017
163
0.130
 Why?
Seroepidemiologic Studies
3
2014
166
0.130
 Why?
Decision Making
1
2024
961
0.120
 Why?
Adiponectin
1
2018
241
0.120
 Why?
Sex Work
1
2016
22
0.120
 Why?
Plasma Cells
1
2016
74
0.120
 Why?
Hydrolases
2
2021
58
0.120
 Why?
Tomography, X-Ray Computed
5
2025
2746
0.120
 Why?
Estradiol
3
2017
528
0.120
 Why?
HLA Antigens
1
2017
233
0.120
 Why?
Respiratory Function Tests
3
2025
567
0.120
 Why?
Sensitivity and Specificity
3
2018
1973
0.120
 Why?
Diagnosis, Differential
3
2013
1498
0.120
 Why?
Idiopathic Pulmonary Fibrosis
2
2019
659
0.120
 Why?
Peptides
1
2021
978
0.110
 Why?
Mothers
1
2021
785
0.110
 Why?
Neutrophils
1
2021
1282
0.110
 Why?
Diet
2
2020
1282
0.110
 Why?
Tertiary Prevention
1
2014
3
0.110
 Why?
Cardiovascular Diseases
3
2017
2087
0.110
 Why?
Vasodilation
3
2013
516
0.110
 Why?
Adaptation, Psychological
1
2000
677
0.110
 Why?
Drug Therapy, Combination
2
2021
1040
0.100
 Why?
Alcohol Drinking
1
2020
834
0.100
 Why?
Blood Pressure
2
2017
1748
0.100
 Why?
Neoplasms
2
2017
2741
0.100
 Why?
Secondary Prevention
1
2014
241
0.100
 Why?
Respiratory Mucosa
1
2016
330
0.100
 Why?
Receptors, Tumor Necrosis Factor
1
2013
166
0.100
 Why?
Bacteroidaceae Infections
1
2012
9
0.100
 Why?
Porphyromonas gingivalis
1
2012
23
0.100
 Why?
Family Health
2
2013
194
0.100
 Why?
Primary Prevention
1
2014
202
0.100
 Why?
Delivery of Health Care
1
2020
961
0.100
 Why?
Vitamin D
2
2022
397
0.100
 Why?
Immune Tolerance
1
2014
368
0.090
 Why?
Periodontitis
1
2012
53
0.090
 Why?
Communicable Disease Control
2
2024
83
0.090
 Why?
Asthma
1
2024
1913
0.090
 Why?
Health
1
2012
84
0.090
 Why?
Arthrography
1
2011
19
0.090
 Why?
Stress, Psychological
1
2020
1128
0.090
 Why?
Population Surveillance
1
2015
481
0.090
 Why?
Telomere Shortening
2
2024
19
0.090
 Why?
Pneumonia, Bacterial
1
2013
117
0.090
 Why?
Delayed Diagnosis
1
2012
93
0.090
 Why?
RNA, Messenger
3
2025
2828
0.090
 Why?
Disease Susceptibility
3
2021
352
0.090
 Why?
Predictive Value of Tests
3
2013
2070
0.090
 Why?
Proportional Hazards Models
3
2021
1261
0.090
 Why?
Breast Neoplasms
1
2023
2250
0.090
 Why?
Logistic Models
5
2020
2086
0.080
 Why?
Labor, Induced
1
2011
36
0.080
 Why?
Antibodies, Monoclonal, Murine-Derived
1
2011
96
0.080
 Why?
Follow-Up Studies
4
2019
5200
0.080
 Why?
Time-to-Treatment
1
2012
217
0.080
 Why?
Phenotype
4
2023
3166
0.080
 Why?
Cyclophosphamide
1
2011
256
0.080
 Why?
Reproducibility of Results
3
2020
3348
0.080
 Why?
Immunoglobulins, Intravenous
1
2011
128
0.080
 Why?
Vasodilator Agents
1
2012
330
0.080
 Why?
Health Knowledge, Attitudes, Practice
1
2018
1396
0.080
 Why?
Statistics, Nonparametric
1
2010
434
0.080
 Why?
Menopause
1
2012
320
0.080
 Why?
Air Pollution
1
2013
322
0.080
 Why?
Colorado
3
2020
4610
0.080
 Why?
Respiratory Insufficiency
1
2013
326
0.080
 Why?
Community-Institutional Relations
1
2009
101
0.080
 Why?
Aging
1
2019
1892
0.070
 Why?
Treatment Outcome
3
2021
11120
0.070
 Why?
Odds Ratio
3
2018
1052
0.070
 Why?
Interleukin-6
3
2021
792
0.070
 Why?
Prognosis
3
2026
4073
0.070
 Why?
Aspirin
1
2011
385
0.070
 Why?
Alleles
3
2019
891
0.070
 Why?
Adrenal Cortex Hormones
1
2011
501
0.070
 Why?
Colposcopy
1
2007
22
0.070
 Why?
Obesity
1
2020
3004
0.070
 Why?
Disease Outbreaks
1
2010
419
0.070
 Why?
Brachial Artery
3
2013
204
0.070
 Why?
Societies, Medical
2
2021
855
0.060
 Why?
Stroke
1
2015
1154
0.060
 Why?
Contraceptives, Oral, Hormonal
1
2006
29
0.060
 Why?
Zimbabwe
1
2025
61
0.060
 Why?
Mice
4
2025
18048
0.060
 Why?
Environment
2
2019
341
0.060
 Why?
Switzerland
1
2025
39
0.060
 Why?
Capillaries
1
2005
125
0.060
 Why?
Premenopause
2
2017
122
0.060
 Why?
Radiography, Thoracic
1
2005
178
0.060
 Why?
Healthy Volunteers
2
2017
214
0.050
 Why?
Bronchoscopy
1
2005
226
0.050
 Why?
Arthritis, Juvenile
1
2005
54
0.050
 Why?
Receptors, CXCR5
1
2024
23
0.050
 Why?
Pregnancy
2
2021
7070
0.050
 Why?
Quarantine
1
2024
31
0.050
 Why?
Immunity, Mucosal
2
2014
96
0.050
 Why?
Phosphopyruvate Hydratase
1
2023
27
0.050
 Why?
Interleukin-2
2
2016
453
0.050
 Why?
Aged, 80 and over
3
2024
7856
0.050
 Why?
Pulmonary Alveoli
1
2005
410
0.050
 Why?
Vimentin
1
2023
52
0.050
 Why?
Antibodies
1
2005
409
0.050
 Why?
Biopsy
1
2005
1081
0.050
 Why?
Health Policy
1
2025
403
0.050
 Why?
Multivariate Analysis
2
2021
1490
0.050
 Why?
Employment
1
2024
181
0.050
 Why?
Immunoglobulins
2
2015
168
0.040
 Why?
Tissue Distribution
1
2022
330
0.040
 Why?
Carotid Arteries
2
2013
201
0.040
 Why?
Hydroxyeicosatetraenoic Acids
1
2021
44
0.040
 Why?
Body Mass Index
2
2020
2382
0.040
 Why?
Adolescent
5
2025
22007
0.040
 Why?
Poverty
1
2025
530
0.040
 Why?
Janus Kinase Inhibitors
1
2021
27
0.040
 Why?
Surveys and Questionnaires
2
2014
5929
0.040
 Why?
Putrescine
1
2020
3
0.040
 Why?
Butyric Acid
1
2020
7
0.040
 Why?
Xenobiotics
1
2021
32
0.040
 Why?
Herpesvirus 4, Human
1
2022
165
0.040
 Why?
Genetic Markers
1
2022
343
0.040
 Why?
Vitamins
1
2022
184
0.040
 Why?
Spermidine
1
2020
19
0.040
 Why?
Telomere
1
2024
277
0.040
 Why?
Immunosuppressive Agents
1
2005
854
0.040
 Why?
Caprylates
1
2020
28
0.040
 Why?
Urban Population
1
2024
485
0.040
 Why?
Docosahexaenoic Acids
1
2021
86
0.040
 Why?
Tumor Necrosis Factor Ligand Superfamily Member 14
1
2020
3
0.040
 Why?
Phosphatidylethanolamines
1
2020
76
0.040
 Why?
Europe
1
2021
410
0.040
 Why?
Chemokine CXCL13
1
2020
12
0.040
 Why?
Carnitine
1
2020
82
0.040
 Why?
Chemokine CXCL9
1
2020
25
0.040
 Why?
Microbiota
2
2021
767
0.040
 Why?
Synovial Fluid
1
2020
73
0.040
 Why?
Survival Analysis
2
2017
1319
0.040
 Why?
Acute-Phase Proteins
1
2020
66
0.040
 Why?
Chemokine CXCL10
1
2020
38
0.040
 Why?
Interleukin-8
1
2021
273
0.040
 Why?
RNA, Viral
1
2024
693
0.040
 Why?
Flow Cytometry
1
2024
1197
0.040
 Why?
Child Health
1
2021
154
0.040
 Why?
Interleukin-1alpha
1
2020
57
0.040
 Why?
Methionine
1
2020
159
0.040
 Why?
Fluorescent Antibody Technique
1
2020
386
0.040
 Why?
Antibody Specificity
1
2020
187
0.040
 Why?
Ontario
1
2000
95
0.040
 Why?
Interinstitutional Relations
1
2000
54
0.040
 Why?
Anxiety
1
2007
1082
0.040
 Why?
Disease Models, Animal
1
2010
4404
0.040
 Why?
Baltimore
1
2019
57
0.040
 Why?
International Cooperation
1
2020
203
0.040
 Why?
Tryptophan
1
2020
188
0.040
 Why?
Endotoxins
1
2020
220
0.040
 Why?
Rural Population
1
2024
604
0.040
 Why?
Interleukin-1beta
1
2021
380
0.040
 Why?
Genotype
2
2018
1859
0.040
 Why?
Interferons
1
2020
195
0.040
 Why?
Receptors, Antigen, T-Cell
1
2023
720
0.040
 Why?
Epitopes, B-Lymphocyte
1
2018
17
0.040
 Why?
Dysbiosis
1
2020
180
0.040
 Why?
Interleukins
1
2020
248
0.040
 Why?
Forecasting
1
2020
384
0.040
 Why?
Mice, Knockout
1
2025
3068
0.030
 Why?
Reactive Oxygen Species
1
2021
630
0.030
 Why?
Nurses
1
2020
184
0.030
 Why?
Tobacco Products
1
2019
129
0.030
 Why?
Gene Frequency
1
2019
494
0.030
 Why?
Consensus
1
2021
704
0.030
 Why?
Antibodies, Viral
1
2022
653
0.030
 Why?
Gene Regulatory Networks
1
2020
313
0.030
 Why?
Polymorphism, Single Nucleotide
2
2019
2132
0.030
 Why?
Genetic Testing
1
2020
460
0.030
 Why?
Biomarkers, Tumor
1
2024
1251
0.030
 Why?
Goserelin
1
2017
8
0.030
 Why?
Membrane Glycoproteins
1
2020
501
0.030
 Why?
Child
4
2025
22308
0.030
 Why?
Amino Acids
1
2021
497
0.030
 Why?
Fertility Agents, Female
1
2017
21
0.030
 Why?
Raloxifene Hydrochloride
1
2017
15
0.030
 Why?
Leuprolide
1
2017
21
0.030
 Why?
Decision Support Techniques
1
2021
431
0.030
 Why?
Selective Estrogen Receptor Modulators
1
2017
32
0.030
 Why?
Genes, Immunoglobulin Light Chain
1
2016
4
0.030
 Why?
Genes, Immunoglobulin Heavy Chain
1
2016
9
0.030
 Why?
Phosphofructokinase-2
1
2016
15
0.030
 Why?
Estrogens, Conjugated (USP)
1
2017
51
0.030
 Why?
Aromatase Inhibitors
1
2017
58
0.030
 Why?
Ataxia Telangiectasia Mutated Proteins
1
2016
66
0.030
 Why?
Phylogeny
1
2021
1018
0.030
 Why?
Bacteria
1
2023
881
0.030
 Why?
Protective Factors
1
2016
96
0.030
 Why?
Carrier Proteins
1
2020
740
0.030
 Why?
Models, Statistical
1
2020
671
0.030
 Why?
Patient Satisfaction
1
2000
695
0.030
 Why?
Antibodies, Monoclonal
1
2022
1448
0.030
 Why?
Androgens
1
2017
187
0.030
 Why?
Health Education
1
2018
357
0.030
 Why?
Symptom Assessment
1
2016
129
0.030
 Why?
Gonadotropin-Releasing Hormone
1
2017
213
0.030
 Why?
T-Lymphocytes
1
2023
2002
0.030
 Why?
Leukocyte Count
1
2015
328
0.030
 Why?
Hypercholesterolemia
1
2015
101
0.030
 Why?
Transcriptome
1
2021
1003
0.030
 Why?
Child, Preschool
2
2025
11457
0.030
 Why?
Promoter Regions, Genetic
1
2018
1242
0.030
 Why?
Etanercept
1
2013
61
0.030
 Why?
Sequence Analysis, DNA
1
2016
824
0.030
 Why?
HLA-DRB1 Chains
1
2014
112
0.030
 Why?
Testosterone
1
2017
404
0.020
 Why?
Motivation
1
2018
602
0.020
 Why?
Pneumocystis carinii
1
2013
11
0.020
 Why?
Geographic Information Systems
1
2013
46
0.020
 Why?
High-Throughput Nucleotide Sequencing
1
2016
546
0.020
 Why?
Magnetic Resonance Imaging
1
2025
3709
0.020
 Why?
Oral Health
1
2014
138
0.020
 Why?
Interleukin-9
1
2012
13
0.020
 Why?
Cell Membrane
1
2016
724
0.020
 Why?
Communication
1
2018
945
0.020
 Why?
Comorbidity
1
2017
1662
0.020
 Why?
Fatal Outcome
1
2013
309
0.020
 Why?
Life Style
1
2014
482
0.020
 Why?
Dietary Supplements
1
2016
566
0.020
 Why?
Immunologic Factors
1
2014
248
0.020
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2012
159
0.020
 Why?
Connective Tissue Diseases
1
2012
85
0.020
 Why?
Polymerase Chain Reaction
1
2014
1056
0.020
 Why?
Mutation
1
2022
4013
0.020
 Why?
Erythrocytes
1
2016
699
0.020
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2013
348
0.020
 Why?
Environmental Monitoring
1
2013
371
0.020
 Why?
Particulate Matter
1
2013
330
0.020
 Why?
Internet
1
2014
690
0.020
 Why?
Exercise
1
2021
2103
0.020
 Why?
Overweight
1
2014
587
0.020
 Why?
Body Composition
1
2013
701
0.020
 Why?
Interferon-gamma
1
2012
792
0.020
 Why?
Self Report
1
2013
856
0.020
 Why?
Ultrasonography
1
2012
755
0.020
 Why?
Gene Expression Regulation
1
2016
2599
0.020
 Why?
Bottle Feeding
1
2007
20
0.020
 Why?
Histocompatibility Testing
1
2007
123
0.020
 Why?
Algorithms
1
2014
1763
0.020
 Why?
Hypertension
1
2015
1252
0.020
 Why?
Diabetes Mellitus
1
2015
1074
0.020
 Why?
Veterans
1
2018
1514
0.020
 Why?
Tobacco Smoke Pollution
1
2007
256
0.010
 Why?
Siblings
1
2005
216
0.010
 Why?
Uterine Cervical Neoplasms
1
2007
287
0.010
 Why?
Pain
1
2007
781
0.010
 Why?
Randomized Controlled Trials as Topic
1
2007
1556
0.010
 Why?
Arthritis, Infectious
1
1994
73
0.010
 Why?
Diabetes Mellitus, Type 1
1
2006
3776
0.000
 Why?
Deane's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (469) concept(s)
_
Co-Authors Expand Description
See all (65) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)